Convexity Labs

ACGL

Convexity Analyst · ACGL
Holdmedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: Arch Capital Group Ltd. (ACGL)

Date: 2026-06-13 Current Price: $91.18

1. Structural Readiness

  • State: Context-Only
  • Conservative Entry:
  • Extension:
  • Breakout Level:
  • ATR at Breakout:
  • ATR Current: 2.0% (Sub-threshold)
  • Pivot Strength:

2. Thesis Layer

This is a TACTICAL, setup-led name with NO named secular thesis at this date. The investment case must be judged strictly on the quality of the technical setup (which is currently absent) and the underlying business fundamentals. There is no macro or secular narrative (e.g., "rate cut beneficiary," "AI disruption," or "hard market cycle peak") attached to this specific setup in the current evidence base. The conviction must derive entirely from the strength of the balance sheet, underwriting discipline, and capital allocation strategy as reported by management.

3. Business Overview

Arch Capital Group Ltd. is a Bermuda-exempted company operating globally in insurance, reinsurance, and mortgage insurance. As of March 31, 2026, the company reported approximately $26.9 billion in capital and is a component of the S&P 500 index.

  • Segments & Operations:
  • Reinsurance: The company acts as an insurer for other carriers, covering casualty, workers' compensation, marine, aviation, and catastrophe risks. In Q1 2026, the reinsurance group achieved a 76% combined ratio, marking the fourth consecutive quarter of sub-80% performance.
  • Mortgage Insurance: This segment delivered $221 million in underwriting income and $266 million in net premiums returned for the quarter. The largest single customer accounted for 5.3% of gross premiums written in 2025.
  • Insurance (Direct): Provides a wide array of products including casualty, property, energy, marine, aviation, and specialized solutions like captive insurance and surety bonds.
  • Recent M&A: On August 1, 2024, the company completed the acquisition of the U.S. MidCorp and Entertainment insurance business from Allianz (the "MCE Acquisition"). Management views this as a strategic ballast and an entry into the entertainment niche.
  • Capital Allocation & Guidance:
  • Share Repurchases: On April 19, 2026, management increased the authorization for its share repurchase program by $3.0 billion. As of May 1, 2026, approximately $3.0 billion remained available under the program. In 2025, the company repurchased approximately $1.9 billion of common shares.
  • Investment Commitments: Unfunded investment commitments stood at approximately $3.9 billion as of March 31, 2026.
  • Operational Guidance: Management expects nonrenewals to reduce net premium return by approximately $250 million throughout 2026. They also noted that current year catastrophe losses were $174 million, driven by winter storms and the Iran conflict.

4. Archetype and Conviction

  • Archetype: Quality Compounder.
  • Rationale: The company demonstrates a disciplined underwriting culture (76% combined ratio), consistent capital generation ($4.4 billion net income in 2025), and aggressive capital return via buybacks ($3.0 billion new authorization). The acquisition of the MCE business and the rapid 18-month systems transformation (leveraging AI) suggest a management team focused on efficiency and strategic growth.
  • Valuation Context:
  • Book value per share was $65.11 at December 31, 2025, rising from $53.11 a year prior.
  • Forward consensus EPS is estimated at $9.28 for FY1 and $9.93 for FY2.
  • At a current price of $91.18, the stock trades at a premium to the most recent book value, reflecting the market's pricing of the company's high ROE and capital return profile.
  • Conviction Stack:
  • Thesis Strength: Low (No named secular thesis).
  • Evidence Quality: High (Strong earnings transcripts and SEC filings confirming profitability and capital deployment).
  • Structural Quality: N/A (No defined setup).
  • Setup Readiness: None (Context-only).
  • Rerating Potential: Dependent on the continuation of sub-80% combined ratios and the successful integration of the MCE acquisition.

5. Invalidations, Strengtheners, and Gaps

  • Invalidation Factors:
  • A sustained combined ratio rising above 80% for consecutive quarters would challenge the "Quality Compounder" thesis.
  • A significant increase in catastrophe losses beyond the current $174 million run-rate without corresponding premium pricing adjustments.
  • Failure to execute the $3.0 billion share repurchase authorization due to capital constraints or regulatory changes.
  • Strengtheners:
  • Continued sub-80% combined ratios in subsequent quarters.
  • Successful integration of the MCE business leading to accretive earnings.
  • Acceleration of the AI-driven systems transformation improving operating leverage.
  • Evidence Gaps:
  • Sector Specifics: The industry classification is listed as "Financial Services," but the specific sub-industry (e.g., "Property & Casualty Reinsurance") is not explicitly detailed in the provided evidence block, though implied by operations.
  • Forward Guidance: While 2026 nonrenewal impacts are quantified, specific guidance for 2027 or beyond is not provided in the source documents.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: 76% combined ratio for four straight quarters; $3.0 billion share repurchase authorization increase; $4.4 billion net income in 2025; Book value growth from $53.11 to $65.11 in one year. Key risks: $250 million reduction in net premium return from nonrenewals in 2026; $174 million in current year catastrophe losses; lack of defined technical setup for entry; sub-threshold ATR indicating low volatility momentum. Expected path: Management expects to deploy capital via buybacks and integrate the MCE acquisition while maintaining underwriting discipline; the stock likely consolidates as the market digests the 2026 nonrenewal headwinds. Expected horizon: 6 to 12 months for the structural setup to form or for the 2026 guidance to be tested. Failure mode to watch: A combined ratio breach above 80% or a significant drop in book value per share due to unanticipated losses.

Loading chart...
Exhibit 1: ACGL daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for ACGL.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for ACGL.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: